Global Nanotechnology Market for Energy Storage – Analysis and Forecasts to 2015—Aarkstore Enterprise Market Research Aggregation

Summary

New report, Global Nanotechnology Markets for Energy Storage – Analysis and Forecasts to 2015″, provides key data, information and analysis on the market opportunities in the nanotechnology enabled energy storage market. The report provides key market trends and competitive landscape analysis for the market. The research discusses market dynamics in detail by providing analytical content on the key challenges for the commercialization of nanotechnology. The report’s coverage of the nanotechnology enabled energy storage market is comprehensive with dedicated sections on the state of research, patent analysis, and key supplier profiles.

Scope

– Qualitative analysis of market drivers, restraints, future outlook, and challenges for the global nano-based energy storage market.
– Comprehensive coverage of R&D initiatives in nanotechnology for energy storage products.
– Competitive landscape section that provides company share information for 2008. Key players covered include Altair Nanotechnologies Inc, Valence Technology Inc., mPhase Technologies Inc., Nanoexa, Inc., and Maxwell Technologies Inc.
– Market sizing (revenue) forecasts for the lithium ion and ultracapacitors market from 2009 to 2015
– Key topics covered include nanotechnology enabled batteries, the ultracapacitor market potential, the state of research, and patent activities analysis.

Reasons to buy

- Gain most up to date information and analysis on the potential opportunities and challenges in the Global Nanotechnology Markets for Energy Efficiency and Energy Storage
- Identify growth segments and opportunities in the Global Nanotechnology Markets for Energy Efficiency and Energy Storage
- Facilitate decision-making based on strong historic and forecast data, deal analysis and recent developments
- Drive business decisions based on the analysis of key players and their market share
- Develop strategies based on the latest operational and regulatory events in the world
- Understand potential market opportunities in various geographies and fine tune your business strategy

For more information, please visit:

http://www.aarkstore.com/reports/Global-Nanotechnology-Market-for-Energy-Storage-Analysis-and-Forecasts-to-2015-40775.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

Drug Delivery Markets: Implantable / Injectable And Needle-Free Delivery Systems

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

Needle-free drug delivery

Other Injectable/Implantable

Kalorama’s unique analysis offers segmentation of this market for:

Drug Delivery Technology Revenues

Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

Detailed Profiles of Key Companies in Implantable/Injectable Delivery

Brief Round-Up of Smaller Players

Current Market Size and Forecasts to 2013

Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments

Revenue Forecasts

New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

Alkermes, Inc.

ALZA Corp.

Antares Pharma, Inc.

Bioject Medical Technologies, Inc.

CyDex, Inc.

MGI Pharma, Inc

Nektar Therapeutics

Pacira Pharmaceuticals, Inc.

pSivida

SurModics, Inc

Zogenix Corporation

AP Pharma

Baxter BioPharma Solutions

QLT USA, Inc

Ypsomed Holding AG

Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1655/Drug-Delivery-Markets-Implantable-Injectable-and-Needle-Free-Delivery-Systems.html

Contact Us:

Visionshopsters
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

New Report On Medical Imaging Markets: Contrast Agents Added In Visionshopsters

The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.

Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of imaging equipment, it has not had a significant negative impact on the use of contrast agents with the equipment already on hand. Specifically, annual growth for medical contrast media during the next five years appears to be strong, despite the recession slowing capital equipment purchases. Imaging exams are still needed for many diagnoses, and contrast enhancement facilitates diagnosis in many cases. Kalorama expects growth ranges to remain high.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama’s medical imaging market reports. Coverage includes:

World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2012. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)

Market share of the major contrast agent supplers

Procedure volumes by modality and region

Estimates of the portion of procedures in each modality using contrast enhancement

Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging’s role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer’s, and other indications are also reviewed.

The report concludes with profiles of top suppliers and developers including:

Acusphere Inc.

Alseres Pharmaceuticals Inc.

Amag Pharmaceuticals Inc.

Aposense Ltd.

Avid Radiopharmaceuticals Inc.

Bayer Schering Pharma

Bracco SpA

Cell Point

Covidien Ltd.

Daiichi Pharmaceutical Co. Ltd.

Dendritic NanoTechnologies Inc.

Draximage

Endocyte Inc.

Eusa Pharma

GE Healthcare

Guerbet Group

Hovione FarmaCiencia SA

Imcor Pharmaceutical Co.

Immunomedics Inc.

Insight Agents GmbH

King Pharmaceuticals Inc.

Luna nanoWorks

Macrocyclics

MDS Nordion

NanoScan Imaging

Palatin Technologies Inc.

Pharmacyclics

Point Biomedical Corp.

Starpharma Holdings Ltd.

VisEn Medical Inc.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1659/Medical-Imaging-Markets-Contrast-Agents.html

Contact Us:

Visionshopsters
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com